Clinical Trials Logo

Clinical Trial Details — Status: Active, not recruiting

Administrative data

NCT number NCT04786119
Other study ID # CORI.2019.07
Secondary ID
Status Active, not recruiting
Phase N/A
First received
Last updated
Start date February 17, 2021
Est. completion date October 17, 2024

Study information

Verified date May 2024
Source Smith & Nephew, Inc.
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Background: REAL INTELLIGENCE™ CORI™ (CORI Robotics) is a computer-assisted orthopaedic surgical navigation and burring system. CORI Robotics is designed to help surgeons in planning and executing certain types of knee surgery involving bone preparation. These types of surgery are called 'unicondylar knee arthroplasty' (UKA) and 'total knee arthroplasty' (TKA). Purpose: This study is being carried out to demonstrate the safety and effectiveness of the CORI Robotics. The data collected will be used to meet the post-market clinical follow-up requirement in Europe and to support claims and publications. Objectives: The primary objective of this study is to evaluate the use of CORI Robotics in UKA and TKA procedures in achieving post-operative leg alignment to check that the results of the operation are similar to what the surgeon originally planned. Research participants / locations: 140 research participants will be recruited from up to 8 sites in 4 countries globally (UK, US, Germany and India). There will be 70 patients having UKA surgery and 70 patients having TKA surgery.


Recruitment information / eligibility

Status Active, not recruiting
Enrollment 126
Est. completion date October 17, 2024
Est. primary completion date October 27, 2023
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - The subject's treating clinician has decided that REAL INTELLIGENCE™ CORI™ and a compatible Smith+Nephew Knee Implant System is the best treatment for the subject's unicondylar knee arthroplasty (UKA) or total knee arthroplasty (TKA) and the subject has agreed to the treatment. - Subject requires a cemented UKA or TKA as a primary indication that meets either criterion A or B. - A. Subject requires a cemented UKA as a primary indication due to any of the following conditions: 1. Non-inflammatory degenerative joint disease, including osteoarthritis 2. Avascular necrosis 3. Requires correction of functional deformity 4. Requires treatment of fractures that were unmanageable using other techniques - B. Subject requires a cemented TKA as a primary indication due to any of the following condition: 1. Degenerative joint disease, including osteoarthritis 2. Rheumatoid arthritis 3. Avascular necrosis 4. Requires correction of functional deformity 5. Requires treatment of fractures that were unmanageable using other techniques - Subject is of legal age to consent and considered skeletally mature (= 18 years of age at the time of surgery) - Subject agrees to consent to and to follow the study visit schedule (as defined in the study protocol and informed consent form), by signing the Ethical Committee (EC) or Institutional Review Board (IRB) approved informed consent form. - Subject plans to be available through one (1) year postoperative follow-up. - Routine radiographic assessment is possible. - Subject able to follow instructions and deemed capable of completing all study questionnaires. Exclusion Criteria: - Subject receives a CORI Robotics UKA or TKA on the index joint as a revision for a previously failed surgery, or need for complex implants, or any other implant than a standard UKA or TKA (e.g. stems, augments, or custom made devices). - Subject has been diagnosed with post-traumatic arthritis - Subject receives bilateral UKA or TKA - Subject does not understand the language used in the Informed Consent Form. - Subject does not meet the indication or is contraindicated for UKA or TKA according to specific Smith+Nephew knee system's Instructions For Use (IFU). - Subject has active infection or sepsis (treated or untreated). - Subject is morbidly obese with a body mass index (BMI) greater than 40. - Subject is pregnant or breast feeding at the time of surgery. - Subject, in the opinion of the Investigator, has advanced osteoarthritis or joint disease at the time of surgery and was better suited for an alternate procedure. - Subject has a condition(s) that may interfere with the TKA or UKA survival or outcome (i.e., Paget's or Charcot's disease, vascular insufficiency, muscular atrophy, uncontrolled diabetes, moderate to severe renal insufficiency or neuromuscular disease, or an active, local infection). - Subject in the opinion of the Investigator, has an emotional or neurological condition that would pre-empt their ability or willingness to participate in the study including mental illness, mental retardation, drug or alcohol abuse. - Subject, in the opinion of the Investigator, has a neuromuscular disorder that prohibited control of the index joint. - Subject is a prisoner or meets the definition of a Vulnerable Subject per ISO 14155 Section 3.55.

Study Design


Related Conditions & MeSH terms


Intervention

Device:
CORI Robotics
Knee arthroplasty with robotics assisted surgery using the CORI Robotics System.

Locations

Country Name City State
Germany Orthopaedic clinic of the Medical School Hannover Hannover
Germany Pius-Hospital Oldenburg Oldenburg
India Lokmanya Hospital Pune Maharashtra
United Kingdom The Royal Orthopaedic Hospital NHS Foundation Trust Birmingham West Midlands
United States Duke Health Morrisville North Carolina
United States OrthoNeuro New Albany Ohio
United States Orthopedic Institute of the West Phoenix Arizona
United States Oregon Health & Science University Portland Oregon

Sponsors (1)

Lead Sponsor Collaborator
Smith & Nephew, Inc.

Countries where clinical trial is conducted

United States,  Germany,  India,  United Kingdom, 

Outcome

Type Measure Description Time frame Safety issue
Primary Post-operative leg alignment Post-operative leg alignment via radiographic assessment. Post-operative leg alignment is achieved when the deviation from the subject specific target does not exceed ±3 degrees. 6 weeks
Secondary Component Alignment - UKA Component alignment will be assessed on long leg standing antero-posterior (A/P) X-rays and standard non weight bearing lateral X-rays taken 6 weeks after surgery in UKA subjects. 6 weeks
Secondary Component Alignment - TKA Component alignment will be assessed on long leg standing antero-posterior (A/P) X-rays and standard non weight bearing lateral X-rays taken 6 weeks after surgery in TKA subjects 6 weeks
Secondary Radiographic assessment - UKA Radiographic assessment on antero-posterior (A/P) and lateral (L) views shall be performed to identify the presence of radiolucent lines, osteolysis & implant migration in UKA subjects 12 months
Secondary Radiographic assessment - TKA Radiographic assessment on antero-posterior (A/P) and lateral (L) views shall be performed to identify the presence of radiolucent lines, osteolysis & implant migration in TKA subjects 12 months
Secondary 2011 Knee Society Score (KSS) - UKA The Functional Knee Score is derived from assessments of walking and standing, standard activities, advanced activities, and discretionary activities in UKA subjects. The 2011 Knee Society Score consists of 4 separate sub-scales: (1) An "Objective" Knee Score (seven items: 100 points), (2) A Patient Satisfaction Score (five items: 40 points), (3) A Patient Expectation Score (three items: 15 points), and (4) A Functional Activity Score (19 items: 100 points). A higher number is a better outcome. Pre-op, 6 week, 6 month and 12 months
Secondary 2011 Knee Society Score (KSS) - TKA The Functional Knee Score is derived from assessments of walking and standing, standard activities, advanced activities, and discretionary activities in TKA subjects. The 2011 Knee Society Score consists of 4 separate sub-scales: (1) An "Objective" Knee Score (seven items: 100 points), (2) A Patient Satisfaction Score (five items: 40 points), (3) A Patient Expectation Score (three items: 15 points), and (4) A Functional Activity Score (19 items: 100 points). A higher number is a better outcome. Pre-op, 6 week, 6 month and 12 months
Secondary Oxford Knee Score (OKS) - UKA To specifically assess the patient's perspective of outcome following knee arthroplasty surgery in UKA subjects. Responses to each question ranges from 0-4 with a range of a possible overall score from 0-48. A score of 0 is the worst possible outcome while a score of 48 is the best possible outcome. Pre-op, 6 week, 6 month and 12 months
Secondary Oxford Knee Score (OKS) - TKA To specifically assess the patient's perspective of outcome following knee arthroplasty surgery in TKA subjects. Responses to each question ranges from 0-4 with a range of a possible overall score from 0-48. A score of 0 is the worst possible outcome while a score of 48 is the best possible outcome. Pre-op, 6 week, 6 month and 12 months
Secondary Forgotten Joint Score (FJS) - UKA To assess joint-specific patient reported outcomes in UKA subjects. Responses to 12 questions are recorded with a five point Likert response format: "Never", "almost never", "seldom", "sometimes" and "mostly". The item scores are summed and linearly transformed in a 0 to 100 scale and then reversed with a high value reflecting the ability of the subject to forget about the replaced knee joint during the activities of daily living. A score of 100 is the best possible outcome. 6 week, 6 month and 12 months
Secondary Forgotten Joint Score (FJS) - TKA To assess joint-specific patient reported outcomes in TKA subjects. Responses to 12 questions are recorded with a five point Likert response format: "Never", "almost never", "seldom", "sometimes" and "mostly". The item scores are summed and linearly transformed in a 0 to 100 scale and then reversed with a high value reflecting the ability of the subject to forget about the replaced knee joint during the activities of daily living. A score of 100 is the best possible outcome. 6 week, 6 month and 12 months
Secondary Five-level EuroQol five-dimensional (EQ-5D-5L) VAS & index scores - UKA To assess the subject's health state in UKA subjects. The EQ-5D-5L is composed of the EQ-5D-5L descriptive system and the EQ Visual Analogue scale (EQ VAS).
The descriptive system comprises 5 dimensions (mobility, self care, usual activities, pain/discomfort, anxiety/depression). Each dimension has 5 levels: no problems, slight problems, moderate problems, severe problems, and extreme problems. Responses are coded as single-digit numbers expressing the severity level selected in each dimension. For instance, 'slight problems' (e.g. 'I have slight problems in walking about') is always coded as '2'. The digits for the five dimensions are combined in a 5-digit code. The EQ- 5D-5L index value is derived by using the vendor supplied calculator to convert each 5-digit EQ-5D-5L profile.
The EQ VAS corresponds to a 20 cm vertical, visual analogue scale raging from 'the best health you can imagine' to 'the worst health you can imagine'.
A higher number is a better outcome.
Pre-op, 6 week, 6 month and 12 months
Secondary Five-level EuroQol five-dimensional (EQ-5D-5L) VAS & index scores - TKA To assess the subject's health state in TKA subjects. The EQ-5D-5L is composed of the EQ-5D-5L descriptive system and the EQ Visual Analogue scale (EQ VAS).
The descriptive system comprises 5 dimensions (mobility, self care, usual activities, pain/discomfort, anxiety/depression). Each dimension has 5 levels: no problems, slight problems, moderate problems, severe problems, and extreme problems. Responses are coded as single-digit numbers expressing the severity level selected in each dimension. For instance, 'slight problems' (e.g. 'I have slight problems in walking about') is always coded as '2'. The digits for the five dimensions are combined in a 5-digit code. The EQ- 5D-5L index value is derived by using the vendor supplied calculator to convert each 5-digit EQ-5D-5L profile.
The EQ VAS corresponds to a 20 cm vertical, visual analogue scale raging from 'the best health you can imagine' to 'the worst health you can imagine'.
A higher number is a better outcome.
Pre-op, 6 week, 6 month and 12 months
See also
  Status Clinical Trial Phase
Not yet recruiting NCT06323980 - INHANCE Stemless Reverse Shoulder IDE N/A
Completed NCT00762944 - Total Temporomandibular Joint Replacement System Post Approval Study
Not yet recruiting NCT05015101 - Evaluation of the Clinical and Radiological Outcome of Uncemented Femoral Stems According to Their Proximal Coating
Terminated NCT02713906 - Materialise X-ray Knee Guides for Total Knee Arthroplasty N/A
Completed NCT02554149 - Radiological Measurement of Femoral Stem Version Using Lateral Decubitus Method: A Prospective Study N/A
Recruiting NCT02828293 - Understanding GMK Sphere Implant Tibiofemoral Kinematics by Means of Dynamic Videofluoroscopy
Completed NCT02829866 - AMIStem-H Radiographic Analysis
Terminated NCT00683267 - Efficacy and Safety Study of 4975 in Patients Undergoing Total Hip Replacement Phase 2
Completed NCT04516239 - Comparison of Metal on Metal Total Hip Arthroplasty and Metal on Metal Total Hip Resurfacing. Phase 4
Recruiting NCT04480320 - Sonography-guided Pericapsular Never Group Block for Hip Arthroplasty N/A
Not yet recruiting NCT04906681 - Implementation of a Rehabilitation Technology in Orthopedic and Neurological Rehabilitation to Increase Therapy Dosage: an Exploratory Study Phase 1/Phase 2
Completed NCT04403919 - Knotless Suture in Revision Total Joint Arthroplasty N/A
Completed NCT03132831 - Influence of the Operative Day on the Average Duration of Stay in Primary Hip and Knee Replacements
Active, not recruiting NCT03339557 - Comparison of Three Knee Replacements N/A
Active, not recruiting NCT02578446 - Uncemented Tritanium Compared With Cemented Metal-backed Tibia Components in Total Knee Replacement N/A
Not yet recruiting NCT00756483 - Stability Plus - Outcomes From Extended Continuum of Care N/A
Terminated NCT00364533 - A Study to Evaluate the Effectiveness and Safety of Tapentadol(CG5503) in the Treatment of Acute Pain After Hip Replacement Surgery Compared With Oxycodone and Placebo Followed by a Voluntary Open-Label Extension For Safety Phase 3
Terminated NCT04089371 - A Post-Market Clinical Evaluation of the ReUnion Reversible Fracture (RFX) System
Completed NCT05248854 - Effects of Sensorimotor and Core Stabilization Exercises After Total Knee Arthroplasty N/A
Not yet recruiting NCT02465684 - Effect of Tourniquet on UKA N/A